Shire (SHPG) Upgraded to “Sell” by BidaskClub
BidaskClub upgraded shares of Shire (NASDAQ:SHPG) from a strong sell rating to a sell rating in a research note published on Friday.
Other equities analysts have also recently issued reports about the company. Royal Bank of Canada set a $192.00 price objective on Shire and gave the stock a buy rating in a research note on Monday, February 5th. Bank of America raised their price objective on Shire from $236.00 to $237.00 and gave the stock a buy rating in a research note on Monday, February 5th. Zacks Investment Research upgraded Shire from a sell rating to a hold rating in a research note on Tuesday, February 6th. Cantor Fitzgerald set a $222.00 price objective on Shire and gave the stock a buy rating in a research note on Wednesday, January 3rd. Finally, Sanford C. Bernstein upgraded Shire from a market perform rating to an outperform rating in a research note on Wednesday, February 14th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have issued a buy rating to the stock. Shire presently has a consensus rating of Buy and a consensus price target of $204.00.
Shares of Shire (NASDAQ SHPG) traded up $0.19 on Friday, reaching $133.38. The company had a trading volume of 293,278 shares, compared to its average volume of 1,480,495. Shire has a 52-week low of $123.73 and a 52-week high of $192.15. The company has a market capitalization of $40,076.07, a PE ratio of 9.48, a PEG ratio of 0.77 and a beta of 1.44. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.97 and a quick ratio of 0.55.
The business also recently announced a semiannual dividend, which will be paid on Tuesday, April 24th. Shareholders of record on Friday, March 9th will be given a $0.8937 dividend. The ex-dividend date of this dividend is Thursday, March 8th. This is a positive change from Shire’s previous semiannual dividend of $0.15. This represents a yield of 1.33%. Shire’s dividend payout ratio (DPR) is currently 6.55%.
A number of hedge funds and other institutional investors have recently modified their holdings of SHPG. Westpac Banking Corp acquired a new stake in Shire in the third quarter worth $587,000. Goelzer Investment Management Inc. increased its holdings in shares of Shire by 7.2% during the third quarter. Goelzer Investment Management Inc. now owns 24,151 shares of the biopharmaceutical company’s stock valued at $3,698,000 after purchasing an additional 1,617 shares during the period. Seizert Capital Partners LLC increased its holdings in shares of Shire by 13.3% during the third quarter. Seizert Capital Partners LLC now owns 10,786 shares of the biopharmaceutical company’s stock valued at $1,652,000 after purchasing an additional 1,267 shares during the period. First Merchants Corp acquired a new position in shares of Shire during the third quarter valued at $1,100,000. Finally, Seatown Holdings Pte. Ltd. acquired a new position in shares of Shire during the third quarter valued at $46,400,000. 19.44% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION WARNING: “Shire (SHPG) Upgraded to “Sell” by BidaskClub” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://www.dailypolitical.com/2018/03/05/shire-shpg-upgraded-to-sell-by-bidaskclub.html.
Shire Company Profile
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.